EGFR-mutated lung cancer

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

April, 2025

EGFR-mutated lung cancer

Nov 26, 2024, 12:04 | Blog

Antonio Passaro: Discussing advancements in the therapeutic landscape of EGFR-mutated lung cancer

Antonio Passaro, Medical oncologist at the European Institute of Oncology in Milan, shared a post…

Aug 19, 2024, 16:16 | Insight

Capmatinib and nazartinib shows promise in EGFR-mutated Lung Cancer resistant to prior treatments

EGFR Positive UK shared a post on X: "Capmatinib and nazartinib shows promise in patients with…

Aug 16, 2024, 13:08 | Blog

Another new member to Lung Cancer Europe EGFR Positive UK

Lung Cancer Europe posted on X: "We are pleased to welcome another new member to LuCE…

All: 3 Posts: 1 - 100

'

Karen Knudsen has been appointed as the CEO of the Parker Institute for Cancer Immunotherapy

'

Highlights from ELCC 2025

'

FDA Approved Pluvicto (177Lu-PSMA-617) for Metastatic Castration-Resistant Prostate Cancer

'

Meet the New AACR Board of Directores for 2025-2028 Term

'

Do Artificial Sweeteners Cause Cancer? Myths and Facts

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023